Brief: Vivesto Strengthens Cantrixil Program With New Preclinical Results And Patent Application

Vivesto AB

19/12/2024 10:00

Dec 19 (Reuters) - Vivesto AB  VIVE.ST :
    * VIVESTO AB - NEW PATENT APPLICATION COVERING TREATMENT OF
HEMATOLOGICAL CANCER WITH CANTRIXIL WAS FILED

Source text:  ID:nMFN9wqtSR 
Further company coverage:  VIVE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))